Marshall Wace’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-15,300
Closed -$865K – 2493
2023
Q2
$865K Sell
15,300
-31,500
-67% -$1.75M ﹤0.01% 1780
2023
Q1
$2.71M Buy
46,800
+32,200
+221% +$2.17M 0.01% 1290
2022
Q4
$1.06M Buy
+14,600
New +$1.05M ﹤0.01% 2059
2021
Q4
– Sell
-5,100
Closed -$314K – 4131
2021
Q3
$314K Buy
+5,100
New +$307K ﹤0.01% 2627
2021
Q2
– Sell
-5,000
Closed -$304K – 2895
2021
Q1
$304K Buy
+5,000
New +$276K ﹤0.01% 2123

Other funds holding MET

Marshall Wace's MET Position: Q3 2026 in Review

Marshall Wace opened a new position in MetLife (MET) in Q3 2026: 903,607 shares worth $85.1M. The stake represents 0.07% of the portfolio and ranks #230 among its holdings. This is a return to the name: Marshall Wace previously reported a position in MET as recently as Q4 2025.

Marshall Wace first reported a position in MET in Q1 2015 and has held it in 21 quarters since. 1,309 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Marshall Wace held 903,607 shares of MetLife worth $85.1M as of Q3 2026.
  • MetLife was a new Marshall Wace position in Q3 2026.
  • MetLife made up 0.07% of Marshall Wace's portfolio in Q3 2026, its #230 holding.
  • Marshall Wace first reported a position in MetLife in Q1 2015 and has held it in 21 quarters since.
  • 1,309 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.